The Tennis Anti-Doping Program is a comprehensive and internationally recognized drug-testing strategy that applies to all players competing at tournaments sanctioned by the ITF, ATP and the WTA.

The goals of the Tennis Anti-Doping Program are as follows:
  • Maintain the integrity of tennis
  • Protect the health and rights of all tennis players

The Tennis Anti-Doping Program maintains a common set of rules and procedures that apply across all levels of tennis. Players are tested for banned substances in accordance with the prevailing version of the World Anti-Doping Agency's Prohibited List. The Tennis Anti-Doping Program is fully compliant with the World Anti-Doping Code.

Since 2007, the ITF has managed, administered and enforced the Tennis Anti-Doping Program on behalf of the WTA. In 2010, the Program conducted over 2,000 doping control tests, both in-competition and out-of-competition, and including both urine and blood samples. An out-of-competition testing program has been conducted under the Tennis Anti-Doping Program since 2005. This program has been fully WADA Code-compliant since out-of-competition testing became mandatory in 2009. Players subject to this program provide daily whereabouts information in order to permit effective no-notice out-of-competition testing.